We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
-$20.8M
Cap. Flow
-$39.5M
Cap. Flow %
-2.66%
Top 10 Hldgs %
46.58%
Holding
135
New
2
Increased
16
Reduced
37
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.09M
2
MSFT icon
Microsoft
MSFT
+$4.03M
3
V icon
Visa
V
+$2.27M
4
NVO
Novo Nordisk
NVO
+$1.24M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$981K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$15.7M
2
META icon
Meta Platforms (Facebook)
META
+$6.33M
3
INTC icon
Intel
INTC
+$5.53M
4
EBAY icon
eBay
EBAY
+$4.55M
5
SNPS icon
Synopsys
SNPS
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 44.99%
2 Communication Services 15.72%
3 Healthcare 14.39%
4 Consumer Discretionary 11.2%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COHU icon
76
Cohu
COHU
$1.86B
$2.15M 0.14%
83,704
– –
VEEV icon
77
Veeva Systems
VEEV
$33.8B
$2.15M 0.14%
10,221
– –
MOH icon
78
Molina Healthcare
MOH
$10.4B
$2.12M 0.14%
6,164
– –
JKHY icon
79
Jack Henry & Associates
JKHY
$11.5B
$2.08M 0.14%
11,786
-1,000
-8% -$169K
CNC icon
80
Centene
CNC
$30.5B
$2.07M 0.14%
27,560
– –
FTNT icon
81
Fortinet
FTNT
$112B
$2.01M 0.14%
25,980
– –
MRK icon
82
Merck
MRK
$322B
$1.95M 0.13%
17,168
– –
SIMO icon
83
Silicon Motion
SIMO
$7.05B
$1.87M 0.13%
30,810
– –
JNJ icon
84
Johnson & Johnson
JNJ
$640B
$1.65M 0.11%
10,183
– –
ZS icon
85
Zscaler
ZS
$24.9B
$1.64M 0.11%
9,568
– –
KAI icon
86
Kadant
KAI
$3.58B
$1.58M 0.11%
4,668
– –
CTRA
87
DELISTED
Coterra Energy
CTRA
$1.56M 0.1%
65,000
-11,541
-15% -$285K
SYK icon
88
Stryker
SYK
$135B
$1.55M 0.1%
4,304
– –
MDT icon
89
Medtronic
MDT
$112B
$1.5M 0.1%
16,662
– –
PCTY icon
90
Paylocity
PCTY
$7.76B
$1.47M 0.1%
8,930
– –
BIO icon
91
Bio-Rad Laboratories Class A
BIO
$8.75B
$1.37M 0.09%
4,107
– –
IBM icon
92
IBM
IBM
$214B
$1.31M 0.09%
5,904
-642
-10% -$126K
INCY icon
93
Incyte
INCY
$25.4B
$1.29M 0.09%
19,522
– –
PYPL icon
94
PayPal
PYPL
$50.3B
$1.28M 0.09%
16,421
-19,896
-55% -$1.33M
BBSI icon
95
Barrett Business Services
BBSI
$1B
$1.26M 0.08%
33,463
-7,061
-17% -$249K
ICFI icon
96
ICF International
ICFI
$1.5B
$1.11M 0.07%
6,672
– –
NVO
97
Novo Nordisk
NVO
$228B
$1.11M 0.07%
+9,283
New +$1.24M
ESAB icon
98
ESAB
ESAB
$5.37B
$1.06M 0.07%
9,980
– –
PBH icon
99
Prestige Consumer Healthcare
PBH
$2.47B
$1.05M 0.07%
14,555
– –
KFRC icon
100
Kforce
KFRC
$1.05B
$963K 0.06%
15,671
– –
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Oak Associates held 135 positions worth $1.49B, down 1.4% from $1.51B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates's Q3 2024 filing shows 2 new, 16 increased, 37 reduced and 6 closed positions. Its largest new stake was Novo Nordisk: 9,283 shares worth $1.11M. The largest sale was KLA, an estimated $15.7M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 46% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q3 2024 buy was Novo Nordisk: 9,283 shares worth $1.11M.
  • Oak Associates added most to Pfizer in Q3 2024, an estimated $5.09M increase.
  • Oak Associates's biggest Q3 2024 reduction was KLA, cutting an estimated $15.7M.
  • Oak Associates fully exited Intel in Q3 2024, selling an estimated $5.53M.
  • Oak Associates's ten largest holdings make up 47% of its $1.49B portfolio in Q3 2024.
  • Oak Associates opened 2 new positions and closed 6 in Q3 2024.
  • Oak Associates's portfolio value fell 1.4% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q3 2024, filed 12 Nov 2024.